12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Deals

LabCorp, Orchid Cellmark deal

LabCorp extended its tender offer to acquire Orchid Cellmark for $2.80 per share, or about $85.4...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >